Gourt > Health > Pharmacy > Drugs and Medications > T > Tirofiban
Basic Chemical and Pharmacological Information
Tirofiban is a synthetic, nonpeptide inhibitor acting at glycoprotein-(GP)-receptors, type IIb/IIIa, in human thrombocytes. It therefore constitutes an anticoagulant, specifically an inhibitor of thrombocyte aggregation.
The drug is marketed in many countries under the brand name Aggrastat® by either MSD Sharp & Dohme or Guilford.
More on [ Tirofiban ]
Tirofiban - Twitter Search
Tirofiban as adjunctive therapy for acute coronary syndromes: a meta-analysis of randomized trials. Eur Heart J 2009. http://tiny.cc/SgdrG
sbhci_org_br (SBHCI) Sun, 01 Nov 2009 22:54:01 -0000
Tirofiban as adjunctive therapy for acute coronary syndromes: a meta-analysis of randomized trials. Eur Heart J 2009. http://tiny.cc/SgdrG
Subscribe to Tirofiban RSS feed 
Tirofiban as adjunctive therapy for acute coronary syndromes: a meta-analysis of randomized trials. Eur Heart J 2009. http://tiny.cc/SgdrG
sbhci_org_br (SBHCI) Sun, 01 Nov 2009 22:54:01 -0000
Tirofiban as adjunctive therapy for acute coronary syndromes: a meta-analysis of randomized trials. Eur Heart J 2009. http://tiny.cc/SgdrG
Aggrastat - Information from Merck. (tirofiban HCI)
Aggrastat Consumer Information - FDA - Consumer FAQ in html format with a link to approved labeling in pdf format.
